CD19 and dermatomyositis: We found that one patient with amyopathic dermatomyositis (Patient 4) showed CD19– cells expressing AIRE before the treatment (i.e. 1.9% in a circled area of Supplementary figure 1b), whereas two healthy donors and the other five patients (Supplementary table 1) had no AIRE+ cells in the peripheral blood.